NCT06846658 · ACTIVE NOT RECRUITING
Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease
This study looks at nose lining samples, blood, and urine to find early biomarkers, which are measurable signs in the body, of Parkinson's disease, multiple system atrophy, and Lewy body dementia. The goal is more accurate early diagnosis by detecting misfolded alpha-synuclein protein. No drug is being tested. The phase is not specified, and it appears to be a diagnostic research study.
You may qualify if
- PD (Postuma et al., 2015), MSA (Palma et al., 2018), DLB (McKeith et al., 2017), OND including acquired and hereditary ataxic syndrome with known etiology, progressive supranuclear palsy, corticobasal degeneration, and motor neuron disease.
You're excluded if
- na
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2026-08-28